Objective Zafirlukast, leukotriene receptor antagonist, is introduced in this study to investigate its effect on exercise induced bronchospasm.
目的研究白三烯受体拮抗剂-扎鲁司特对运动性哮喘的治疗作用。
Montelukast, a Selective Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces Cerulein-Induced Pancreatic Injury in Rats.
孟鲁司特，选择性白三烯受体1拮抗物，能减少雨蛙肽诱导的胰腺损害。
Montelukast, a Selective Cysteinyl Leukotriene Receptor 1 Antagonist, Reduces Cerulein-Induced Pancreatic Injury in Rats.
孟鲁司特，选择性白三烯受体1拮抗物，能减少雨蛙肽诱导的胰腺损害。
应用推荐